Bio-thera Solutions, Ltd. Class ASSE: 688177

Announcement on FDA Approval for BAT2206 (Ustekinumab) Injection in the United States

· Issued by Bio-thera Solutions, Ltd. Class A via Shanghai Stock Exchange
Announcement on FDA Approval for BAT2206 (Ustekinumab) Injection in the United States

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment